Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Sphingosine-1 phosphate and central nervous system.
The need for randomization in animal trials: an overview of systematic reviews.
JC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection.
Olfactory bulb and olfactory sulcus depths are associated with disease duration and attack frequency in multiple sclerosis patients.
Is membrane homeostasis the missing link between inflammation and neurodegenerative diseases?
Symptomatic management in multiple sclerosis.
Measures of aging with disability in U.S. secondary data sets: Results of a scoping review.
An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trial.
Cognitive-motor related brain activity during walking: differences between men and women with multiple sclerosis.
Nogo Receptor Signaling Restricts Adult Neural Plasticity by Limiting Synaptic AMPA Receptor Delivery.
Is environmental radon gas associated with the incidence of neurodegenerative conditions? A retrospective study of multiple sclerosis in radon affected areas in England and Wales.
Multiple sclerosis treatment: risk mitigation.
A forgotten aspect of the NICE reference case: an observational study of the health related quality of life impact on caregivers of people with multiple sclerosis.
OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology.
IgM-monoclonal gammopathy neuropathy and tremor: A first epidemiologic case control study.
Immunodetection of outer membrane proteins by flow cytometry of isolated mitochondria.
In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics.
Trace elements in scalp hair samples from patients with relapsing-remitting multiple sclerosis.
Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect.
Computerised cognitive training in acquired brain injury: A systematic review of outcomes using the International Classification of Functioning (ICF).
What are exosomes and how can they be used in multiple sclerosis therapy?
Improving multiple sclerosis care: an analysis of the necessity for medication therapy management services among the patient population.
A Review of the Psychometric Properties of Generic Utility Measures in Multiple Sclerosis.
Physical Disability, Anxiety and Depression in People with MS: An Internet-Based Survey via the UK MS Register.
High CD6 and low chemokine receptor expression on peripheral blood lymphocytes correlates with MRI gadolinium enhancement in MS.
Pages
« first
‹ previous
…
477
478
479
480
481
482
483
484
485
…
next ›
last »